Livzon Pharmaceutical Group Inc. researches, develops, produces, exports, and sells pharmaceutical products, and active pharmaceutical ingredients (API) and int...
Livzon Pharmaceutical’s First-Quarter Profit Slips as Policy Shift and Seasonality Hit Revenue
Livzon Pharmaceutical Outlines Board and Committee Structure
LIVZON PHARMA adjusts the maximum cost of acquiring its Vietnamese peer to RMB 1.85 billion
LIVZON PHARMA's application for marketing authorization of Lecanemab injection has been accepted
On November 3rd, LIVZON PHARMA spent CNY 5.9969 million to repurchase 164,000 A shares
LIVZON GROUP has repurchased 1.7% of its shares at a cost of 570 million yuan